tiprankstipranks
Innate Pharma (IPHA)
NASDAQ:IPHA
US Market
IPHA
Innate Pharma
RESEARCH TOOLSreports
Want to see IPHA full AI Analyst Report?

Innate Pharma (IPHA) Balance Sheet

142 Followers

Innate Pharma Balance Sheet

Innate Pharma's total assets for Q4 2025 were €62.69M, a decrease of -32.54% from the previous quarter. IPHA total liabilities were €84.39M for the fiscal quarter, a -3.88% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
€ 62.69M€ 111.06M€ 175.19M€ 207.86M€ 267.50M
Total Liabilities
€ 84.39M€ 102.22M€ 132.29M€ 153.71M€ 160.06M
Total Equity Gross Minority
€ -21.69M€ 8.83M€ 51.90M€ 54.15M€ 107.44M
Other Metrics
Currency in EUR

Innate Pharma Debt to Assets